Kenya - English - Pharmacy and Poisons Board

lg chem, ltd, e14 block lg science park, 70, magokjungang - inactivated poliovirus types 1, 2 and 3(sabin… - solution for injection - a single human dose (0.5 ml) of sabin inactivated… - poliomyelitis trivalent inactivated whole virus

Ireland - English - HPRA (Health Products Regulatory Authority)

animal health distributors limited - bovine respiratory syncytial virus, strain bio-24, inactivated; bovine parainfluenza 3 virus, strain bio-23, inactivated; mannheimia haemolytica, serotype a1 strain dsm 5283, inactivated; bovine viral diarrhoea virus, strain bio-25, inactavited - suspension for injection - . relative potency/dose - bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella

Ireland - English - HPRA (Health Products Regulatory Authority)

animal health distributors limited - bovine respiratory syncytial virus, strain bio-24 inactivated; bovine parainfluenza 3 virus, strain bio-23, inactivated; mannheimia haemolytica, serotype a1 strain dsm 5283, inactivated - suspension for injection - . relative potency/dose - bovine parainfluenza virus + bovine respiratory syncytial virus + pasteurella

Canada - English - Health Canada

valneva sweden ab - vibrio cholerae ogawa 50 classical biotype, formalin inactivated; recombinant cholera toxin b subunit; vibrio cholerae inaba 6973 el tor biotype, formalin inactivated; vibrio cholerae inaba 48 classical biotype, heat inactivated; vibrio cholerae ogawa 50 classical biotype, heat inactivated - suspension - 31250000000cells; 1mg; 31250000000cells; 31250000000cells; 31250000000cells - vibrio cholerae ogawa 50 classical biotype, formalin inactivated 31250000000cells; recombinant cholera toxin b subunit 1mg; vibrio cholerae inaba 6973 el tor biotype, formalin inactivated 31250000000cells; vibrio cholerae inaba 48 classical biotype, heat inactivated 31250000000cells; vibrio cholerae ogawa 50 classical biotype, heat inactivated 31250000000cells - vaccines

Singapore - English - HSA (Health Sciences Authority)

aenon pharmaceuticals sea pte. ltd. - recombinant cholera toxin b subunit (rctb); vibrio cholerae o1 inaba classic strain (heat inactivated); vibrio cholerae o1 inaba el tor strain (formalin inactivated); vibrio cholerae o1 ogawa classic strain (formalin inactivated); vibrio cholerae o1 ogawa classic strain (heat inactivated) - suspension - 1 mg/dose - recombinant cholera toxin b subunit (rctb) 1 mg/dose; vibrio cholerae o1 inaba classic strain (heat inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 inaba el tor strain (formalin inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 ogawa classic strain (formalin inactivated) 31.25 x 10^9 bacteria; vibrio cholerae o1 ogawa classic strain (heat inactivated) 31.25 x 10^9 bacteria

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur msd ltd - purified diphtheria toxoid ph. eur., purified tetanus toxoid, adsorbed purified pertussis toxoid, adsorbed purified filamentous haemagglutinin, inactivated poliomyelitis virus ph. eur, inactivated type 1 poliovirus, inactivated type 2 poliovirus, inactivated type 3 poliovirus, haemophilus influenzae type b, conjugate with tetanus protein - powder for suspension for injection - 0 %v/v - bacterial and viral vaccines, combined

European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human, immunization, disease outbreaks - vaccines, - active immunisation against h5n1 subtype of influenza a virus., this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain., prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.,

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

boehringer ingelheim animal health australia pty. ltd. - amphotericin b; neomycin; polymixin b; feline leukaemia virus - inactivated; thiomersal - misc. vaccines or anti sera - amphotericin b antibiotic active 0.0 undefined; neomycin antibiotic active 0.0 undefined; polymixin b antibiotic active 0.0 undefined; feline leukaemia virus - inactivated vaccine-viral active 0.0 undefined; thiomersal mercury other 0.0 undefined - immunotherapy - cat | cat - queen | cat - tom | kitten - feline leukaemia virus | disease caused by

Ireland - English - HPRA (Health Products Regulatory Authority)

glaxosmithkline (ireland) limited - pertussis toxoid; filamentous haemagglutinin; pertactin; diphtheria toxoid; tetanus toxoid; polio virus type 1 inactivated; polio virus type 2 inactivated; polio virus type 3 inactivated - suspension for injection in pre-filled syringe - 0.5 millilitre(s) - diphtheria-pertussis-poliomyelitis-tetanus